Back

Residual cholesterol:a non-predictive marker for major adverse cardiovascular events in patients with intermediate coronary lesions: a large-scale multicenter study

30 August 2025 (08:45 - 08:55)
Organised by: Logo
Congress Presentation Part of: Non-obstructive coronary disease: what's new in assessment and management Biomarkers ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Jiayi Ren

2nd Hospital of Tianjin Medical University, Tianjin (China)

5 More presentations in this session

Presentation thumbnail
How late is too late? Influence of CMR timing in suspected MINOCA
Doctor G. Bisaccia (Chieti, IT)
Abstract Slides Video
Presentation thumbnail
Invasive assessment of coronary microvascular function in sepsis: The COronary Microcirculation and Troponin Elevation in Severe Sepsis (COMTESS)-study
Doctor S. Lorstad (Stockholm, SE)
Abstract Slides Video
Presentation thumbnail
Procedural complications during intracoronary acetylcholine provocation testing in patients with cardiac arrest
Doctor K. Tateishi (Chiba, JP)
Abstract Slides Video
Presentation thumbnail
Adherence to consensus recommendations in the care of patients with spontaneous coronary artery dissection from the ANZ-SCAD registry
Doctor Q. Dang (Hamilton, NZ)
Abstract Slides Video
Presentation thumbnail
The influence of endothelial dysfunction and the prognosis in patients with myocardial infarction with non-obstructive coronary arteries.
Mr H. Kondo (Yokohama, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Non-obstructive coronary disease: what's new in assessment and management
Video

The Event

Event poster

ESC Congress 2025

30 August 2025 08:45 CET
You may be interested in
thumbnail
Congress Presentation
Long-term prognostic impact of remnant cholesterol distribution after percutaneous coronary intervention and coronary artery bypass graft: insights from a nationwide cohort
thumbnail
Congress Presentation
Exploring residual cardiovascular risk beyond LDL cholesterol in patients with acute destabilisation of known significant atherosclerosis
thumbnail
Congress Session
Late-Breaking Clinical Science: lipids and cardiovascular risk

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources